Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 2009-02-15 (17 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: COMBS-LA-VILLE (77380), Seine-et-Marne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DU VIEUX PAYS : revenue, balance sheet and financial ratios
PHARMACIE DU VIEUX PAYS is a French company
founded 17 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in COMBS-LA-VILLE (77380),
this company of category PME
shows in 2025 a net income positive of 174 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU VIEUX PAYS (SIREN 511442345)
Indicator
2025
2024
2023
2022
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
174 203 €
120 851 €
114 114 €
219 409 €
249 259 €
193 630 €
205 546 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DU VIEUX PAYS generates positive net income of 174 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 206 k€ -> 174 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
174 203 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 728%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 11%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
728.277%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
10.894%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DU VIEUX PAYS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2022
2023
2024
2025
Debt ratio
72.645
66.001
52.509
618.327
458.394
348.68
728.277
Financial autonomy
55.219
56.007
61.729
12.925
16.806
20.394
10.894
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
728.282025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Watch
In 2025, the debt ratio of PHARMACIE DU VIEUX PAYS (728.28) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
Financial autonomy
10.89%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Watch
In 2025, the financial autonomy of PHARMACIE DU VIEUX PAYS (10.9%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 162.06. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
162.058
Liquidity indicators evolution PHARMACIE DU VIEUX PAYS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2022
2023
2024
2025
Liquidity ratio
219.68
178.591
219.424
268.616
258.93
185.558
162.058
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
162.062025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Average-31 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DU VIEUX PAYS (162.06) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of PHARMACIE DU VIEUX PAYS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DU VIEUX PAYS is estimated at
2 767 235 €
(range 1 877 858€ - 4 342 173€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1877k€2767k€4342k€
2 767 235 €Range: 1 877 858€ - 4 342 173€
NAF 5 année 2025
Valuation method used
Net Income Multiple
174 203 €
×
15.9x
=2 767 235 €
Range: 1 877 859€ - 4 342 173€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU VIEUX PAYS with other companies in the same sector:
Frequently asked questions about PHARMACIE DU VIEUX PAYS
What is the revenue of PHARMACIE DU VIEUX PAYS ?
The revenue of PHARMACIE DU VIEUX PAYS is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DU VIEUX PAYS profitable?
Yes, PHARMACIE DU VIEUX PAYS generated a net profit of 174 k€ in 2025.
Where is the headquarters of PHARMACIE DU VIEUX PAYS ?
The headquarters of PHARMACIE DU VIEUX PAYS is located in COMBS-LA-VILLE (77380), in the department Seine-et-Marne.
Where to find the tax return of PHARMACIE DU VIEUX PAYS ?
The tax return of PHARMACIE DU VIEUX PAYS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU VIEUX PAYS operate?
PHARMACIE DU VIEUX PAYS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart